|
|
Volumn 12, Issue SUPPL. 2, 2007, Pages 1-
|
|
Innovative approaches in the treatment and support of patients with acute myelogenous leukemia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIFUNGAL AGENT;
CYTARABINE;
DAUNORUBICIN;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
INTERFERON;
ANTINEOPLASTIC AGENT;
ACUTE GRANULOCYTIC LEUKEMIA;
ALLOGENIC BONE MARROW TRANSPLANTATION;
BLEEDING;
CARDIOTOXICITY;
EDITORIAL;
GASTROINTESTINAL TOXICITY;
GRANULOCYTE TRANSFUSION;
HUMAN;
INFECTION;
LIVER TOXICITY;
MONOTHERAPY;
MYCOSIS;
NEPHROTOXICITY;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROGNOSIS;
RISK FACTOR;
REVIEW;
STEM CELL TRANSPLANTATION;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
HUMANS;
LEUKEMIA, MYELOID, ACUTE;
STEM CELL TRANSPLANTATION;
TREATMENT OUTCOME;
|
|
EID: 38449087663
PISSN: 10837159
EISSN: 1549490X
Source Type: Journal
DOI: 10.1634/theoncologist.12-1-1 Document Type: Editorial |
|
Times cited : (2)
|
|
References (3)
|
